Trial: Pfizer COVID Vax Effective Against South African Variant

(MedPage Today) -- Pfizer-BioNTech's COVID-19 vaccine appeared to be 100% effective at preventing cases of the South African variant, B.1.351, the two firms announced Thursday.
Topline results from a phase III clinical trial of 800 people in South...